May 02, 2014 15:37 ET
TORONTO, ONTARIO--(Marketwired - May 2, 2014) - Trimel Pharmaceuticals Corporation (TSX:TRL) will report its first quarter financial results for the period ended March 31, 2014 on Thursday, May 8th 2014 after market close.
Management of the Company will host a conference call to discuss these results and update investors on the status of its business on Friday, May 9th 2014, at 8:30 a.m. Eastern Daylight Time. Following the discussion, Trimel executives will address inquiries from investment analysts.
To access the call live, please dial 416-340-2216 or 1-866-223-7781. Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays.
A replay of the conference call will be available until 7:00 p.m. Eastern Daylight Time on Friday, May 16th, 2014 by dialing 905-694-9451 or 1-800-408-3053, using access code: 6382379#.
Trimel is a specialty pharmaceutical company actively developing medications for male hypogonadism, female sexual dysfunction and various respiratory disorders. An NDA for CompleoTRT™, a product utilizing Trimel's licensed bioadhesive intranasal gel technology, has been accepted for review by the FDA for regulatory approval in the United States. For more information, please visit www.trimelpharmaceuticals.com.
Trimel Pharmaceuticals CorporationKenneth HowlingChief Financial Officer(416) firstname.lastname@example.org
See all RSS Newsfeeds